- Home
- UCAR vs XXII Comparison
UCAR vs XXII Comparison
Compare UCAR & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UCAR | XXII |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 7.8M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | UCAR | XXII |
|---|---|---|
| Price | $1.74 | $1.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 22.4K | ★ 191.6K |
| Earning Date | 10-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,816,075.00 | ★ $20,346,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $136.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 57.22 | 16.98 |
| 52 Week Low | $1.71 | $0.78 |
| 52 Week High | $9.43 | $287.27 |
Technical Indicators
Market Signals| Indicator | UCAR | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 44.96 |
| Support Level | $1.71 | $1.06 |
| Resistance Level | $1.91 | $1.17 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 33.96 | 67.12 |
Price Performance
Historical ComparisonAbout UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.